As of the latest Form 4 filed Jul 7, 2026.
What Imunon Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 20 most recent filings for IMNN.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-07 | 2026-07-06 | Eylward Susan General Counsel and Corp Sec | SSale | −920.00 | $1.88 | $1.73K | No | Form 4 ↗ |
| 2026-07-07 | 2026-07-02 | Tardugno Michael H Executive Chairman of Board | AAward | +4.41K | $1.91 | $8.42K | No | Form 4 ↗ |
| 2026-07-07 | 2026-07-02 | Eylward Susan General Counsel and Corp Sec | AAward | +920.00 | $1.91 | $1.76K | No | Form 4 ↗ |
| 2026-07-07 | 2026-07-02 | Faller Douglas Vincent Chief Medical Officer | AAward | +1.31K | $1.91 | $2.50K | No | Form 4 ↗ |
| 2026-07-07 | 2026-07-02 | Lindborg Stacy President and CEO | AAward | +2.53K | $1.91 | $4.84K | No | Form 4 ↗ |
| 2026-06-29 | 2026-06-29 | Eylward Susan General Counsel and Corp Sec | SSale | −11.8K | $1.75 | $20.7K | No | Form 4 ↗ |
| 2026-06-29 | 2026-06-25 | Faller Douglas Vincent Chief Medical Officer | AAward | +21.9K | $1.72 | $37.7K | No | Form 4 ↗ |
| 2026-06-29 | 2026-06-25 | Eylward Susan General Counsel and Corp Sec | AAward | +14.7K | $1.72 | $25.3K | No | Form 4 ↗ |
| 2026-06-29 | 2026-06-25 | Tardugno Michael H Executive Chairman of Board | AAward | +42.5K | $1.72 | $73.1K | No | Form 4 ↗ |
| 2026-06-29 | 2026-06-25 | Lindborg Stacy President and CEO | AAward | +67.2K | $1.72 | $115K | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | Tardugno Michael H Executive Chairman of Board | AAward | +4.63K | $1.82 | $8.42K | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-18 | Lindborg Stacy President and CEO | AAward | +1.80K | $1.82 | $3.28K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | Tardugno Michael H Executive Chairman of Board | AAward | +4.09K | $2.06 | $8.42K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | Lindborg Stacy President and CEO | AAward | +1.59K | $2.06 | $3.28K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Tardugno Michael H Executive Chairman of Board | AAward | +3.48K | $2.20 | $7.66K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Pellizzari Christine A Director | AAward | +5.56K | $2.20 | $12.2K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Dentzer James E Director | AAward | +11.1K | $2.20 | $24.5K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Braun Donald P Director | AAward | +5.01K | $2.20 | $11.0K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Fritz Frederick J. Director | AAward | +10.3K | $2.20 | $22.7K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Lindborg Stacy President and CEO | AAward | +1.49K | $2.20 | $3.28K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also IMNN’s full analysis or the market-wide insider trading feed. The tabs above jump to IMNN’s other SEC data.
Source: SEC Form 4 filings for IMNN, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.